Web Based Renal Transplant Patient Medication Education

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2006 by Agency for Healthcare Research and Quality (AHRQ).
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Agency for Healthcare Research and Quality (AHRQ)
ClinicalTrials.gov Identifier:
NCT00327483
First received: May 16, 2006
Last updated: NA
Last verified: May 2006
History: No changes posted
  Purpose

Information technology will be brought directly to renal transplant recipients to help them learn about the large number of medications they are required to take on a life long basis, in order to prevent errors and improve safety.


Condition Intervention Phase
Renal Transplant Recipients
Behavioral: Internet based education software
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Educational/Counseling/Training
Official Title: Web Based Renal Transplant Patient Medication Education

Resource links provided by NLM:


Further study details as provided by Agency for Healthcare Research and Quality (AHRQ):

Primary Outcome Measures:
  • Medication errors

Secondary Outcome Measures:
  • Serum creatinine
  • Rejection episodes
  • Rehospitalizations
  • Graft loss

Estimated Enrollment: 250
Study Start Date: July 2005
Estimated Study Completion Date: April 2006
Detailed Description:

Transplant recipients are particularly vulnerable to medication errors because of the large number of chronic drugs needed to prevent rejection and treat comorbidities. Compliance failures directly compromise patient safety through acute immunologic events and premature graft loss. For society, the loss of invested fiscal and organic (organs) resources is catastrophic. As the unique constant in the chain of people who provide, modify and consume prescription medications, health information technology should be focused on empowering the patient to prevent medication errors. Our principal clinical hypothesis is that HIT can be proven to improve patient safety by minimizing medication errors. Specific aims address the creation of new knowledge and evidence ( in a renal transplant population) of benefits of widely applicable HIT tools. Web enabled education of two groups, new (<6 months) and established (> 6 months), kidney transplant recipients is proposed.

  Eligibility

Ages Eligible for Study:   14 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:age > 18 or capable of managing own medications

-

Exclusion Criteria:Education level below 10th grade

-

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00327483

Locations
United States, Connecticut
Yale New Haven Hospital Recruiting
New Haven, Connecticut, United States, CT
Contact: Amy L Friedman, MD    203-785-2565    amy.friedman@yale.edu   
Principal Investigator: Amy L Friedman, MD         
Sponsors and Collaborators
Investigators
Principal Investigator: Amy L Friedman, MD Yale University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00327483     History of Changes
Other Study ID Numbers: RO1-HS15038-03
Study First Received: May 16, 2006
Last Updated: May 16, 2006
Health Authority: United States: Federal Government

Keywords provided by Agency for Healthcare Research and Quality (AHRQ):
Transplant
Medication error
Patient Safety
Information technology

ClinicalTrials.gov processed this record on September 11, 2014